Stockreport
Arcadia Biosciences Q2 Earnings Per Share $0.84 [Reuters]
Last arcadia biosciences, inc. earnings: 3/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations: ir.arcadiabio.com
Arcadia Biosciences Inc (RKDA.OQ) Key Developments | Reuters.com Aug 14 (Reuters) - Arcadia Biosciences Inc ::Q2 REVENUE $203,000 VERSUS $436,000.QTRLY EARNINGS PER SHARE $0.84. Full Article March 15 (Reuters) - Arcadia Biosciences Inc ::ARCADIA BIOSCIENCES RECEIVES FDA APPROVAL FOR SONOVA® GLA SAFFLOWER OIL IN CAT FOOD. Full Article May 11 (Reuters) - Arcadia Biosciences Inc ::ARCADIA BIOSCIENCES FILES FOR MIXED SHELF OF UP TO $50 MILLION - SEC FILING. Full Article March 30 (Reuters) - Arcadia Biosciences Inc ::ARCADIA BIOSCIENCES FILES PROSPECTUS RELATED TO SALE OF UP TO 2.9 MILLION SHARES OF COMMON STOCK BY SELLING SHAREHOLDERS - SEC FILING. Full Article March 20 (Reuters) - Arcadia Biosciences Inc ::ARCADIA BIOSCIENCES ANNOUNCES FOURTH-QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS.Q4 LOSS PER SHARE $1.39.Q4 REVENUE $1.4 MILLION VERSUS $540,000. Full Article March 19 (Reuters) - Arcadia Biosciences Inc ::ARCADIA BIOSCIENCES ANNOUNCES $10 MILLIO
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | RKDA | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
RKDA alerts
RKDA alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
RKDA alerts
High impacting Arcadia Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
RKDA
NEWS
NEWS
- Arcadia Biosciences (RKDA) Announces Third Quarter 2025 Financial Results and Business Highlights [Yahoo! Finance][Yahoo! Finance]
- Arcadia Biosciences (RKDA) Announces Third Quarter 2025 Financial Results and Business Highlights[GlobeNewswire]
- Arcadia Biosciences (NASDAQ:RKDA) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.[MarketBeat]
- SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates HRZN, RKDA, HNI on Behalf of Shareholders[PR Newswire]
- Arcadia Biosciences (NASDAQ:RKDA) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.[MarketBeat]
- More
RKDA
SEC Filings
SEC Filings
- 11/19/25 - Form ARS
- 11/19/25 - Form DEF
- 11/7/25 - Form 10-Q
- RKDA's page on the SEC website
- More